These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8865788)

  • 1. The clinical significance of calculated versus measured creatinine clearance in patients with gynecologic malignancy.
    Rao PS; Fiorica JV; Shah RP; Graham L; Roberts WS; Hoffman MS; Cavanagh D
    South Med J; 1996 Oct; 89(10):967-70. PubMed ID: 8865788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy in gynecologic cancer.
    Smith JP
    Clin Obstet Gynecol; 1975 Dec; 18(4):109-24. PubMed ID: 174855
    [No Abstract]   [Full Text] [Related]  

  • 3. A discussion of the results of chemotherapy on gynecological cancer and the host's immune response.
    Trelford JD
    Proc Natl Cancer Conf; 1970; 6():365-85. PubMed ID: 5458106
    [No Abstract]   [Full Text] [Related]  

  • 4. Polyamine levels in gynecologic malignancies.
    Hayase R; Eguchi K; Sekiba K
    Acta Med Okayama; 1985 Feb; 39(1):35-45. PubMed ID: 3984779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of calculated creatinine clearance as a guide to chemotherapy in patients with gynecologic malignancies.
    Kang SB; Kim BG; Song YS; Lee HP
    J Obstet Gynaecol Res; 1996 Feb; 22(1):67-71. PubMed ID: 8624896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for gynecologic malignancies at Siriraj Hospital, Bangkok.
    Senapad S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):656-9. PubMed ID: 3939044
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of observation of the glucuronization degree in gynecologic carcinomas by means of I 131 -labeled orthoiodine benzoic acid].
    Kolárová O; Stanícek J; Dohnálek J; Eysselt M
    Zentralbl Gynakol; 1970 Mar; 92(12):368-71. PubMed ID: 5535546
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations on gynecologic malignancy treated with 5-fluorouracil.
    Malkasian GD; Decker DG; Mussey E; Johnson CE
    Am J Obstet Gynecol; 1968 Apr; 100(7):1012-7. PubMed ID: 5644296
    [No Abstract]   [Full Text] [Related]  

  • 9. [Criteria for the determination of the immediate efficacy of chemotherapy in gynecologic neoplasms].
    Koto T; Tsunawaki A
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):4262-76. PubMed ID: 3729501
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased nephrotoxicity of combination taxol and cisplatin chemotherapy in gynecologic cancers as compared to cisplatin alone.
    Merouani A; Davidson SA; Schrier RW
    Am J Nephrol; 1997; 17(1):53-8. PubMed ID: 9057954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of kidney function in patients with ovarian cancer treated with chemotherapy: calculation versus measurement of creatine clearance].
    Küng F; Köchli OR; Seifert B; Haller U
    Gynakol Geburtshilfliche Rundsch; 1994; 34(3):157-61. PubMed ID: 7987083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advances in intraarterial chemotherapy in gynecologic malignancy].
    Shimizu Y
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):189-96. PubMed ID: 11865623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin enhancement of cisplatin chemotherapy in patients with refractory gynecologic cancer. A Gynecologic Oncology Group Study.
    Manetta A; Boyle J; Berman ML; DiSaia PJ; Lentz S; Liao SY; Mutch D; Slater L
    Cancer; 1994 Jan; 73(1):196-9. PubMed ID: 8275425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inadequacy of predicted creatinine clearance as guide to chemotherapy.
    McDermott DF; Galindo A; Sherman RL; Jaffe EA; Coleman M; Pasmantier MW
    Cancer Treat Rep; 1987 Nov; 71(11):1067-9. PubMed ID: 3677111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy in gynecologic cancer.
    Smith JP
    Surg Clin North Am; 1978 Feb; 58(1):201-15. PubMed ID: 205960
    [No Abstract]   [Full Text] [Related]  

  • 16. [Assessment of kidney function before cisplatin administration: the need for 24-hour urine collection].
    Ptok M; Ptok A; Schwab M
    HNO; 1989 Feb; 37(2):67-70. PubMed ID: 2703375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for advanced or recurrent gynecologic cancer.
    Thigpen T; Vance R; Lambuth B; Balducci L; Khansur T; Blessing J; McGehee R
    Cancer; 1987 Oct; 60(8 Suppl):2104-16. PubMed ID: 3308070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measured versus estimated creatinine clearance in the elderly as an index of renal function.
    Gral T; Young M
    J Am Geriatr Soc; 1980 Nov; 28(11):492-6. PubMed ID: 7430521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of the creatinine clearance before the administration of chemotherapy with cisplatin.
    Davila E; Gardner LB
    Cancer; 1987 Jul; 60(2):161-4. PubMed ID: 3594352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of chemotherapy in gynecologic cancer.
    Tropé C; Kristensen G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.